Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sativex in Multiple Sclerosis Spasticity
NCT00202423Phase 2Unknown
- Sponsor
- Sant'Andrea Hospital
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cannabidiol in Spasticity (2 arms), sponsored by Sant'Andrea Hospital. Primary endpoints: Patterns of brain activation associated with movement at 7 weeks, Changes in level of spasticity (H-reflex) at 7 weeks and 1 more. Status: unknown.
02
Drugs
cannabidiol
03
Conditions
Spasticity
Beyond the preview
Go deeper on NCT00202423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00202423.